 |
|
|
RedPath’s
PathFinderTG®
represents over 17 years
of research and development and is clinically validated at an average 95% accuracy
rate across multiple organs, specimen types and diagnostic questions
for cancer. |
|
|
|
|
|
|
|
|
RedPath's Mission is to facilitate superior disease diagnosis.
RedPath's Vision is to be recognized by clinicians, pathologists, patients and payors as the source for objective, definitive diagnosis and characterization of cancer resulting in optimal treatment, outcomes and cost.
|
|
|
|
|
|
 |
|
|
|
|
The Bonding of BioBuds
Read
What pathology examination of your Esophageal Biopsy can tell your doctor about the health of your esophagus.
Read
More News |
| |
|
 |
|
|
